Showing results (1011-1020 of 1,068) with videos related to

Sort By:
Pageof 107
Journal of Pharmacokinetics and Pharmacodynamics|November 16, 2012
Bench to bedside translation of antibody drug conjugates using a multiscale mechanistic PK/PD model: a case study with brentuximab-vedotinDhaval K Shah, Nahor Haddish-Berhane, Alison Betts
Journal of Pharmacokinetics and Pharmacodynamics|September 25, 2012
Longitudinal FEV1 dose-response model for inhaled PF-00610355 and salmeterol in patients with chronic obstructive pulmonary diseaseJace C Nielsen, Matthew M Hutmacher, Adriaan Cleton, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 1, 2012
A sequential Monte Carlo approach to derive sampling times and windows for population pharmacokinetic studiesJ M McGree, C C Drovandi, A N Pettitt
Journal of Pharmacokinetics and Pharmacodynamics|August 14, 2012
Extension of NPDE for evaluation of nonlinear mixed effect models in presence of data below the quantification limit with applications to HIV dynamic modelThi Huyen Tram Nguyen, Emmanuelle Comets, France Mentré
Journal of Pharmacokinetics and Pharmacodynamics|January 28, 2022
Physiologically-based pharmacokinetic model for 2,4-dinitrophenolLyndsey F Meyer, Pooja M Rajadhyaksha, Dhaval K Shah
Journal of Pharmacokinetics and Pharmacodynamics|December 6, 2005
Population cell life span models for effects of drugs following indirect mechanisms of actionJuan J Perez-Ruixo, Hui C Kimko, Andrew T Chow, et al.
Journal of Pharmacokinetics and Pharmacodynamics|April 29, 2018
Receptor/gene/protein-mediated signaling connects methylprednisolone exposure to metabolic and immune-related pharmacodynamic actions in liverVivaswath S Ayyar, Siddharth Sukumaran, Debra C DuBois, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 29, 2015
Pharmacokinetics and pharmacodynamics of propofol in cancer patients undergoing major lung surgeryKrzysztof Przybyłowski, Joanna Tyczka, Damian Szczesny, et al.
Pageof 107